Challenges and methodology in the incorporation of biomarkers in cancer clinical trials

Wilhelm-Benartzi, Charlotte ORCID: https://orcid.org/0000-0003-4927-6158, Mt-Isa, Shahrul, Fiorentino, Francesca, Brown, Robert and Ashby, Deborah 2017. Challenges and methodology in the incorporation of biomarkers in cancer clinical trials. Critical Reviews in Oncology/Hematology 110 , pp. 49-61. 10.1016/j.critrevonc.2016.12.008

Preview

PDF - Accepted Post-Print Version Download (595kB) | Preview

Abstract

tBiomarkers can be used to establish more homogeneous groups using the genetic makeup of the tumourto inform the selection of treatment for each individual patient. However, proper preclinical work andstringent validation are needed before taking forward biomarkers into confirmatory studies. Despitethe challenges, incorporation of biomarkers into clinical trials could better target appropriate patients,and potentially be lifesaving. The authors conducted a systematic review to describe marker-based andadaptive design methodology for their integration in clinical trials, and to further describe the associatedpractical challenges. Studies published between 1990 to November 2015 were searched on PubMed.Titles, abstracts and full text articles were reviewed to identify relevant studies. Of the 4438 studiesexamined, 57 studies were included. The authors conclude that the proposed approaches may readilyhelp researchers to design biomarker trials, but novel approaches are still needed.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Uncontrolled Keywords:	Clinical trialsBiomarkersResearch designStatisticalCancera
Publisher:	Elsevier
ISSN:	1040-8428
Date of First Compliant Deposit:	25 January 2017
Date of Acceptance:	12 December 2016
Last Modified:	08 Jan 2024 19:48
URI:	https://orca.cardiff.ac.uk/id/eprint/97742

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item